By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunovaccine Inc. 

1819 Granville Street
Suite 303
Halifax  Nova Scotia  B3J 3R1  Canada
Phone: 902-492-1819 Fax: 902-492-0888




Company News
Immunovaccine Achieves Breakthrough In Support Of Developing Personalized Cancer Immunotherapies 7/12/2017 10:37:01 AM
Immunovaccine Announces Closing Of $10 Million Bought Deal Offering 6/21/2017 7:42:33 AM
Immunovaccine Forms Inaugural Scientific And Clinical Advisory Committee 6/14/2017 12:45:49 PM
Immunovaccine Announces $10 Million Bought Deal Offering 5/31/2017 8:47:32 AM
Immunovaccine Announces Positive Year-Long Immunogenicity Data From Phase I Clinical Trial For Respiratory Syncytial Virus Vaccine Candidate 4/12/2017 9:13:04 AM
Immunovaccine Appoints Seasoned Financial Executive Pierre Labbe As CFO 2/3/2017 10:38:27 AM
Immunovaccine Names Acting Chief and CBO as Permanent CEO 4/13/2016 5:55:38 AM
Immunovaccine Inc. And Leidos Join Forces To Develop A Zika Virus Vaccine Candidate 4/7/2016 10:25:40 AM
Immunovaccine Inc. Announces Financial Results For Quarter Ended September 30, 2015 11/13/2015 1:01:37 PM
Immunovaccine Inc.'s Vaccine Candidate For Respiratory Syncytial Virus Is Well Tolerated In Volunteers In Phase 1 Clinical Trial 10/30/2015 12:42:19 PM